ロード中...
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
PURPOSE OF REVIEW: Chronic lymphocytic leukaemia is now recognised as a heterogenous disease with a variety of clinical outcomes. Here we summarise the way it is currently stratified according to genetic risk and patient characteristics and the treatment approaches used for these different subgroups...
保存先:
| 出版年: | Curr Oncol Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072049/ https://ncbi.nlm.nih.gov/pubmed/32172299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-020-0893-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|